Biofrontera AG | CIK:0001712641 | 3

  • Filed: 4/30/2018
  • Entity registrant name: Biofrontera AG (CIK: 0001712641)
  • Generator: Novaworks Software
  • SEC filing page: http://www.sec.gov/Archives/edgar/data/1712641/000149315218005915/0001493152-18-005915-index.htm
  • XBRL Instance: http://www.sec.gov/Archives/edgar/data/1712641/000149315218005915/bfra-20171231.xml
  • XBRL Cloud Viewer: Click to open XBRL Cloud Viewer
  • EDGAR Dashboard: https://edgardashboard.xbrlcloud.com/edgar-dashboard/?cik=0001712641
  • Open this page in separate window: Click
  • ifrs-full:DescriptionOfAccountingPolicyForImpairmentOfAssetsExplanatory

    Impairment of assets

     

    The company tests assets for impairment when indications exist that the carrying amount of an asset exceeds its recoverable amount. A possible impairment requirement of assets held for use is evaluated by comparing the carrying amount of an asset with the cash flows that the asset is expected to generate in the future. When such an asset is considered to be impaired, the impairment loss is measured at the amount by which the carrying amount of the asset exceeds its recoverable amount. Assets that are to be sold are reported at the lower of the carrying amount or fair value less costs to sell.